NEWS
The Ben and Catherine Ivy Foundation is a prominent philanthropy organisation fully dedicated to improving the survival and quality of life of people diagnosed with brain tumors. The foundation supports promising research at the forefront of scientific discoveries that will have an impact on patient's life. Touring several European research laboratories in search for promising patient-focused research efforts, Ms Ivy also took the time to visit and discuss the ongoing projects of the Norlux Neuro-Oncology team.
Picture from left to right:
JC Schmit, CEO of CRP-Santé; C. Ivy, Board President of the Ivy Foundation; SP Niclou, Head of the Norlux Neuro-Oncology Laboratory; R. Bjerkvig, Head of the Department of Oncology at CRP-Santé.
The Hygiene Institute of the University of Vienna and the LNSI have agreed to collaborate on the development of improved possibilities to diagnose Lyme Disease. Both in Austria and in Luxembourg the disease plays an increasingly important role. Prof. Gerold Stanek, Hygiene Institute Vienna, is one of the outstanding scientists of Europe in the field of Lyme Disease. Since 2007 the Department of Immunology is working on pathogens that are transmitted by ticks. In Luxembourg, 8% of the population and even 35% of the risk groups have contact with Lyme disease, although this does not always lead to disease. Every sixth tick in Luxembourg is infected with Lyme disease and it regularly happens that the pathogen is transmitted to humans in case of a tick bite. The clinical diagnosis of the disease is complicated because of mostly non-specific symptoms and the lack of reliable laboratory diagnostic tests. For this reason, the sometimes heavy disease is often diagnosed late or not at all.
Photo 1 (from left to right): Prof. Dr. Hannes Stockinger, Hygiene-Institute, University of Vienna, Prof. Dr. Claude P. Muller, Department of Immunology, Luxembourg, Prof. Dr. Gerald Stanek, Hygiene-Institute, University of Vienna
Vesna Bosic looked for antiviral effects of garlic on the influenza virus. She has been awarded with the participation at the London International Youth Science Forum – LIYSF, which will take place in August 2013. The LIYSF, founded in 1959, attracts over 300 of the world’s leading young scientists aged 17-21 years old from more than 50 participating countries.
This work, based on a critical analysis of the scientific literature and on experimentations carried out by ANSES, was conducted by an international group of 26 experts, including B. Appenzeller, from the Laboratory of Analytical Human Biomonitoring
, CRP-Santé, who was in charge of assessing the biomonitoring approaches used to evaluate the level of exposure of the population.
Bisphenol A is a synthetic chemical highly used over the past 50 years, mainly for the synthesis of plastics, polymers, in the composition of flame retardants and as revelator in thermo-printed paper (sales receipt).
Several research studies based on in vivo and in vitro models demonstrated the influence of this endocrine disruptor on the onset of reproduction issues, and adverse effects on metabolism and brain.
The report published on the 8th of April, presents the different sources of exposure to Bisphenol A, the levels of exposure observed in the general population, and highlights the possible risk for the unborn child due to mother exposure during pregnancy.
The report can be viewed here: http://www.anses.fr/fr/documents/CHIM2009sa0331Ra-0.pdf
8 pupils and the coordinator Patrick Delhalt spent an afternoon with Josiane Kirpach, Wibke Jochum and Anna Reye in order to learn about ticks and related diseases. The team of Prof. Dr. Claude P. Muller works on new biomarkers for Borreliosis, which should help to facilitate the up to now difficult diagnosis of Borreliosis.
Dr. Anna Chioti, Head of The Clinical and Epidemiological Investigation Center has been nominated Advisory Board Member of The European Society for Translational Medicine (EUSTM) a global non-profit and neutral platform for the advancement and progress of Translational Medicine.
The society aims to facilitate cooperation and interaction among clinicians, basic life scientists, academia, industry, governments, funding and regulatory agencies, investors and policy makers in order to develop and deliver high quality translational medicine programs and initiatives with overall aim to enhance the health care of European and non-European population.
The society's goal is to enhance research and development of novel and affordable diagnostic tools and treatments for clinical disorders affecting European and non-European populations.
Dr. Chioti's presence in the advisory board offers the possibility for CRP-Santé to contribute to the society’s programs/events including webcast, webinars, training courses, conferences and also to contribute with articles on CRP-Santé's areas of interest in the society’s new digital magazine ‘New Horizons in Translational Medicine’: http://www.eutranslationalmedicine.org/publications.